Algorae Pharmaceuticals Ltd (1AI)

8 hours ago

Algorae Pharmaceuticals cardiovascular drug betters beta-blockers in studies

Algorae Pharmaceuticals’ (ASX: 1AI) new AI-168 drug combination that partly involves cannabidiol has shown early potential to improve on...

1 day ago

Johnson & Johnson exec signs on for Algorae Pharmaceuticals AI drug development

Johnson & Johnson exec Dr Sarah Siggins has signed on for ASX-listed Algorae Pharmaceuticals’ (ASX: 1AI) hunt to create drug...

Nov 21

Algorae taps AI to develop anti-cancer drug combos

Medical technology innovator Algorae Pharmaceuticals (ASX: 1AI) has identified 24 different existing drug combinations put together by a...

Sep 24

Algorae Pharmaceuticals AI platform launch set to spark new drug discoveries

Algorae Pharmaceuticals (ASX: 1AI) has supercharged its bid to find and combine previously-approved drugs to create brand new medical...

Jul 31

Dementia combo drug testing shows promise for Algorae Pharmaceuticals

Algorae Pharmaceuticals (ASX: 1AI) has made a significant breakthrough in pre-clinical testing aimed at combating the effects of dementia...

Apr 29

Algorae Pharmaceuticals harnessing AI to meet acute medical needs

With access to a vast data library, including the biggest supercomputer in the Southern Hemisphere, Algorae Pharmaceuticals (ASX: 1AI) is...

Apr 8

Algorae Pharmaceuticals buoyed by test results on dementia treatment

Algorae Pharmaceuticals (ASX: 1AI) says pre-clinical testing on a combination of drugs it is developing to potentially treat dementia...

Mar 8

Algorae closes in on AI drug discovery platform launch

ASX-listed biotech Algorae Pharmaceuticals (ASX: 1AI) says its new AI-driven platform aimed at identifying previously-approved drugs it...